Sermorelin vs. Tesamorelin: How the Two GHRH Analogs Actually Differ

Both sermorelin and tesamorelin belong to the same family: GHRH analogs. Rather than giving you synthetic growth hormone, they signal the pituitary gland to release your own GH through the body's existing pathway. A clinical review has described this approach as more physiologic than direct HGH precisely because it preserves the body's own feedback regulation, which keeps the response self-limiting (Walker, 2006).

That shared mechanism is why the two get compared so often. The differences are mostly about regulatory status, intended use, and availability — not about being fundamentally different kinds of molecules.

Tesamorelin is a stabilized GHRH analog marketed as Egrifta, and it is FDA-approved — a meaningful distinction. Its approval is narrow and specific: it's indicated for the reduction of excess visceral abdominal fat in patients with HIV-associated lipodystrophy, an indication established through controlled clinical trials (Falutz et al., 2007).

Two implications worth being clear about:

• It's a specialty drug for a diagnosed condition, prescribed and monitored in that context — not a general wellness or optimization product, despite how it's sometimes discussed online.
• Its FDA approval is a genuine advantage on the dimensions approval speaks to: it has been through formal review for that indication, with an established label and safety profile.

Protocol MD does not offer tesamorelin. Its approved use falls outside the scope of what we provide, and we're not in a position to prescribe or dispense it.

Sermorelin is also a GHRH analog, but its regulatory situation is different: it is not currently an FDA-approved product in the United States. It's prepared by licensed 503A compounding pharmacies and prescribed by physicians, after evaluation, for growth-hormone-axis support.

Practically, that means sermorelin's use is grounded in clinical practice and physician judgment rather than a specific FDA-approved indication — which is exactly why who prescribes it and where it comes from matters so much. A physician-prescribed, pharmacy-compounded product with a real evaluation behind it is a fundamentally different thing from a "research-only" vial bought online, even when the molecule name matches.

• Regulatory status. Tesamorelin is FDA-approved for a defined indication; sermorelin is compounded and prescribed off-label. This is the single biggest difference.
• Intended population. Tesamorelin is for a diagnosed medical condition. Sermorelin is used more broadly for GH-axis support in appropriate candidates.
• Formulation and duration. Tesamorelin was engineered for greater stability; sermorelin is shorter-acting, which some prescribers view as producing a more pulse-like signal.
• Availability. Tesamorelin is a specialty pharmacy product tied to its indication; sermorelin is more commonly available through compounding pharmacies with a prescription.

Honestly: that's not a question this article can answer, and be skeptical of any page that claims otherwise.

If you have the specific condition tesamorelin is approved to treat, that's a conversation with the physician managing that condition — and its FDA approval matters. If you're exploring growth-hormone-axis support more generally, sermorelin is the option more commonly used in that context, and it requires a physician evaluation to determine whether it's appropriate for you at all.

What's not a good approach for either: deciding based on a forum thread and sourcing the compound yourself. Both are prescription products, and both have gray-market imitations circulating that carry real risks unrelated to the molecules themselves.

To be transparent about our own position: we prescribe physician-prescribed, 503A-compounded sermorelin because growth-hormone-axis support is within the scope of what we do, and because sermorelin fits that use under physician supervision. Tesamorelin's approved indication is a specific HIV-related condition managed in a different clinical context, so we don't offer it.

We'd rather tell you that plainly than pretend the comparison only has one reasonable answer. If you want to see how our side of it works, here's how Protocol MD's physician-prescribed sermorelin works, and our sermorelin dosage guide covers how a protocol is actually set.

So, sermorelin vs. tesamorelin? They're close cousins mechanically — both GHRH analogs that work through your own growth-hormone pathway — but they occupy different regulatory and clinical worlds. Tesamorelin is FDA-approved for a specific diagnosed condition and is managed in that context. Sermorelin is compounded and prescribed more broadly for growth-hormone-axis support, which makes the legitimacy of the source and the quality of the physician evaluation the deciding factors. Protocol MD offers sermorelin, not tesamorelin — and either way, this is a decision to make with a licensed physician rather than from a comparison chart.